All Journals > The Journal of Infectious Diseases > 1 July 2006 > Determinants of Immune Recovery during ART

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 July 2006

Volume 194, Number 1
The Journal of Infectious Diseases 2006;194:29–37
0022-1899/2006/19401-0006$15.00
DOI: 10.1086/504718
MAJOR ARTICLE

Determinants of CD4+ T Cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV‐1 DNA

Miguel Goicoechea,1

Davey M. Smith,1

Lin Liu,2

Susanne May,2

Allan R. Tenorio,3

Caroline C. Ignacio,1

Alan Landay,3,4 and

Richard Haubrich1

1Department of Medicine and 2Division of Biostatistics and Bioinformatics, Department of Family and Preventive Medicine, University of California, San Diego; Departments of 3Medicine and 4Immunology and Microbiology, Rush Medical College, Chicago, Illinois

Background.Suboptimal CD4+ T cell recovery during antiretroviral therapy (ART) is a common clinical dilemma.

Methods.We analyzed viral and immunologic predictors of CD4+ T cell recovery in 116 human immunodeficiency virus type 1 (HIV‐1)–infected subjects who had suppressed viremia (50 copies/mL) while receiving ART. Successive measurements of T cell immunophenotypes and cellular HIV‐1 DNA levels were obtained before and during receipt of ART. On the basis of increases in the CD4+ T cell count, subjects were classified as immunologically concordant (demonstrating an increase of 100 CD4+ T cells/mm3) or discordant (demonstrating an increase of <100 CD4+ T cells/mm3) after 48 weeks of ART.

Results.In adjusted analyses, CD4+ and CD8+ T cell activation at baseline was negatively associated with immunologic concordance at week 48 of ART (odds ratio [OR], 0.80 [ ] and 0.67 [ ], respectively). High memory (CDRACD62L) CD8+ T cell counts at baseline (OR, 0.33 [ ]) predicted less CD4+ T cell recovery, whereas increased naive CD4+ T cell counts were associated with higher increases in CD4+ T cells (OR, 1.19 [ ]). Neither the cell‐associated HIV‐1 DNA level at baseline ( ) nor the cell‐associated HIV‐1 DNA level at week 48 of ART ( ) was associated with immunologic concordance during ART.

Conclusions.These results support the potential clinical usefulness of the baseline determination of immune activation and maturation subsets in the prediction of CD4+ T cell recovery during viral suppression. Furthermore, identification of individuals with reduced potential for CD4+ T cell recovery during ART may provide a rationale for the initiation of early therapy for some patients.

Received 14 December 2005; accepted 23 February 2006; electronically published 18 May 2006.

Reprints or correspondence: Dr. Miguel Goicoechea, University of California, San Diego, Antiviral Research Center, 150 W. Washington St., Ste. 100, San Diego, CA 92131 ().

Cited by

Edouard Tuaillon, Yassine Al Tabaa, Vincent Baillat, Michel Segondy, Marie-Christine Picot, Jacques Reynes, Jean-Pierre Vendrell. (2009) Close association of CD8 + /CD38 bright with HIV-1 replication and complex relationship with CD4 + T-cell count. Cytometry Part B: Clinical Cytometry 76B:4, 249-260
Online publication date: 1-Aug-2009.
CrossRef
Giovanna Melica, Pierre Brugieres, Anne-Sophie Lascaux, Yves Levy, Jean-Daniel Lelièvre. (2009) Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. Journal of Medical Virology 81:4, 578-581
Online publication date: 1-May-2009.
CrossRef
Katharina Schroecksnadel, Christine Winkler, Mario Sarcletti, Nikolaus Romani, Zoltan Banki, Susanne Ebner, Dietmar Fuchs, Robert Zangerle. (2009) Parameters of Soluble Immune Activation In Vivo Correlate Negatively With the Proliferative Capacity of Peripheral Blood Mononuclear Cells In Vitro in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:4, 354-359
Online publication date: 1-May-2009.
CrossRef
Gail Skowron, John G Spritzler, Jodi Weidler, Gregory K Robbins, Victoria A Johnson, Ellen S Chan, David M Asmuth, Rajesh T Gandhi, Yolanda Lie, Michael Bates, Richard B Pollard. (2009) Replication Capacity in Relation to Immunologic and Virologic Outcomes in HIV-1-Infected Treatment-Naive Subjects. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:3, 250-258
Online publication date: 1-Apr-2009.
CrossRef
Gregory K. Robbins, John G. Spritzler, Ellen S. Chan, David M. Asmuth, Rajesh T. Gandhi, Benigno A. Rodriguez, Gail Skowron, Paul R. Skolnik, Robert W. Shafer, Richard B. Pollard, and the AIDS Clinical Trials Group 384 Team. (2009) Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384. Clinical Infectious Diseases 48:3, 350-361
Online publication date: 1-Feb-2009.
Christopher J. Hoffmann, Salome Charalambous, Desmond J. Martin, Craig Innes, Gavin J. Churchyard, Richard E. Chaisson, Alison D. Grant, Katherine L. Fielding, and Chloe L. Thio. (2008) Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program. Clinical Infectious Diseases 47:11, 1479-1485
Online publication date: 1-Dec-2008.
Adriana Weinberg, Ruth Dickover, Paula Britto, Chengcheng Hu, Julie Patterson-Bartlett, Joyce Kraimer, Howard Gutzman, William T Shearer, Mobeen Rathore, Ross McKinney. (2008) Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS 22:17, 2267-2277
Online publication date: 1-Dec-2008.
CrossRef
Denis Nash, Monica Katyal, Martin WG Brinkhof, Olivia Keiser, Margaret May, Rachael Hughes, Francois Dabis, Robin Wood, Eduardo Sprinz, Mauro Schechter, Matthias Egger. (2008) Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 22:17, 2291-2302
Online publication date: 1-Dec-2008.
CrossRef
Michael A Kolber. (2008) CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. AIDS 22:15, 1937-1941
Online publication date: 1-Nov-2008.
CrossRef
Brett D Shepard, Mona R Loutfy, Janet Raboud, Frank Mandy, Colin M Kovacs, Christina Diong, Michele Bergeron, Victoria Govan, Stacey A Rizza, Jonathan B Angel, Andrew D Badley. (2008) Early Changes in T-Cell Activation Predict Antiretroviral Success in Salvage Therapy of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:2, 149-155
Online publication date: 1-Jul-2008.
CrossRef
Peter W. Hunt, Jason Brenchley, Elizabeth Sinclair, Joseph M. McCune, Michelle Roland, Kimberly Page‐Shafer, Priscilla Hsue, Brinda Emu, Melissa Krone, Harry Lampiris, Daniel Douek, Jeffrey N. Martin, and Steven G. Deeks. (2008) Relationship between T Cell Activation and CD4+ T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy. The Journal of Infectious Diseases 197:1, 126-133
Online publication date: 1-Jan-2008.
Peter W. Hunt. (2007) Role of immune activation in HIV pathogenesis. Current HIV/AIDS Reports 4:1, 42
CrossRef
Martyn A. French. (2007) Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Current HIV/AIDS Reports 4:1, 16
CrossRef
  • Presented in part: XVth International AIDS Conference, Bangkok, Thailand, 11–17 July 2004 (abstract MoPeA3079).

    Potential conflicts of interest: none reported.

    Financial support: California Collaborative Treatment Group University‐wide AIDS Research Program (grant CC02‐SD‐003); the Adult AIDS Clinical Trials Group (AACTG) funded by the National Institutes of Allergy and Infectious Diseases (grants 5K23 AI055276, AI27670, and AI043638); the AACTG Central Group (grant U01AI38858); University of California San Diego Center for AIDS Research (grant SP30 AI36214); National Institutes of Health Center of Health (grants AI29164, AI047745, and AI07384); Research Center for AIDS and HIV Infection of the San Diego Veterans Affairs Healthcare System; Pfizer Pharmaceuticals.

Close Popup